Nanoviricides (NNVC) Other Non-Current Liabilities (2013 - 2019)

Nanoviricides has disclosed Other Non-Current Liabilities across 7 years of filings, most recently posting $1.6 million for Q1 2019.

• In Q1 2019, Other Non-Current Liabilities rose 76.54% year-over-year to $1.6 million; the TTM figure through Mar 2019 stood at $1.6 million (up 76.54% YoY), while the FY2017 annual figure was $2.0 million, down 45.31% from the prior year.
• Other Non-Current Liabilities came in at $1.6 million for Q1 2019 at Nanoviricides, up from $902426.0 in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $6.4 million in Q1 2015 to a low of $28284.0 in Q4 2016.
• Average Other Non-Current Liabilities over 5 years is $2.8 million, with a median of $2.4 million recorded in 2015.
• Year-over-year, Other Non-Current Liabilities slumped 99.02% in 2016 and soared 21931.59% in 2017.
• Over 5 years, Other Non-Current Liabilities stood at $2.9 million in 2015, then tumbled by 99.02% to $28284.0 in 2016, then soared by 21931.59% to $6.2 million in 2017, then slumped by 85.52% to $902426.0 in 2018, then jumped by 76.54% to $1.6 million in 2019.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $1.6 million in Q1 2019, $902426.0 in Q1 2018, and $6.2 million in Q4 2017.